- $1.16bn
- $1.44bn
- $568.09m
Bioventus Inc expected to post earnings of 12cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alignment Healthcare, Comerica, M&T Bank Corp
U.S. RESEARCH ROUNDUP-Goodrx Holdings, Nextnav, Olo
Bioventus Inc reports results for the quarter ended in June - Earnings Summary
Brief: Bioventus reports Q2 results
Bioventus Inc expected to post earnings of 16 cents a share - Earnings Preview
Brief: Bioventus Receives FDA 510(K) Clearance For SonaStar Elite
Brief: Bioventus Amends Cartiheal Acquisition Structure
Bioventus Inc reports results for the quarter ended in March - Earnings Summary
Brief: Bioventus Q1 Sales Rose 43.4 Percent To $117.3 Mln
Bioventus Inc expected to post earnings of 5 cents a share - Earnings Preview
Brief: Bioventus Cancels Proposed $415 Million Offering Of Senior Notes, Reaffirms Full-Year 2022 Financial Guidance
Brief: Bioventus Agrees To Nationwide Contract With Cigna Commercial Plans For Durolane And Gelsyn-3
Brief: Bioventus Reports Preliminary Q1 Net Sales, Adjusted EBITDA
Brief: Bioventus Reports $415 Mln Offering Of Senior Notes
U.S. STOCKS ON THE MOVE-SunPower, Snow Lake, Sea Ltd
Bioventus slumps after acquiring remaining stake in implant developer CartiHeal
Brief: Bioventus Exercises Call Option To Acquire Cartiheal
U.S. RESEARCH ROUNDUP- Beauty Health, Mister Car Wash, Nuvei